The American Journal of Surgery
Volume 198, Issue 4 , Pages 505-507 , October 2009

American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis—4-year data in 194 treated lesions

  • Martin Keisch, M.D.

      Affiliations

    • Aventura Comprehensive Cancer Center, Aventura, FL, USA
    • Miami Brachytherapy Center, Miami, FL, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 305 545 6685; fax: +1 305 545 6687
    • ,
  • Frank Vicini, M.D.

      Affiliations

    • Wm. Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Peter Beitsch, M.D.

      Affiliations

    • Dallas Breast Center, Dallas, TX, USA
    • ,
  • Coral Quiet, M.D.

      Affiliations

    • Arizona Oncology, Scottsdale, AZ, USA
    • ,
  • Angela Keleher, M.D.

      Affiliations

    • Western Pennsylvania Hospital, Pittsburgh, PA, USA
    • ,
  • Delia Garcia, M.D.

      Affiliations

    • St. Louis Cancer and Breast Center, St. Louis, MO, USA
    • ,
  • Howard Snider, M.D.

      Affiliations

    • Alabama Breast Center, Montgomery, AL, USA
    • ,
  • Mark Gittleman, M.D.

      Affiliations

    • Sacred Heart Hospital, Allentown, PA, USA
    • ,
  • Victor Zannis, M.D.

      Affiliations

    • Breast Care Center of the Southwest, Phoenix, AZ, USA
    • ,
  • Henry Kuerer, M.D.

      Affiliations

    • M.D. Anderson Hospital, Houston, TX, USA

Received 23 March 2009 ,Revised 27 April 2009

References 

  1. Vicini F, Beitsch P, Quiet C, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity. Cancer. 2005;104:1138–1148
  2. Beitsch P, Vicini F, et al. Recurrence and survival in the American Society of Breast Surgeons MammoSite RTS Registry Trial. Int J Radiat Oncol Biol Phys. 2008;72:S2–S3
  3. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B17. J Clin Oncol. 1998;16:441–452
  4. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24:3381–3387
  5. Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet. 2003;362:95–102
  6. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast (Results of a randomised trial in a population offered mammography screening). Acta Oncol. 2006;45:536–543
  7. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24:1031–1036
  8. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993–2000

PII: S0002-9610(09)00378-X

doi: 10.1016/j.amjsurg.2009.06.013

The American Journal of Surgery
Volume 198, Issue 4 , Pages 505-507 , October 2009

Article Tools